Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sulcardine administration for treatment of acute atrial fibrillation

Sulcardine administration for treatment of acute atrial fibrillation

US Patent 12465587 · Granted Nov 11, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

SHP2 inhibitor monotherapy and uses thereof2025
SHP2 inhibitor monotherapy and uses thereof2025
Sulcardine administration for treatment of acute atrial fibrillation2025
Sulcardine administration for treatment of acute atrial fibrillation2025
Pressure unloading left ventricular assist device and methods for assisting a hu2025
Combination therapies of HDAC inhibitors and PD-1 inhibitors2024
Combination therapies comprising SHP2 inhibitors and PD-1 inhibitors2024
Combination therapies comprising SHP2 inhibitors and PD-1 inhibitors2024
Sulcardine administration for treatment of acute atrial fibrillation2024
Sulcardine administration for treatment of acute atrial fibrillation2024
Sulcardine administration for treatment of acute atrial fibrillation2023
Sulcardine administration for treatment of acute atrial fibrillation2023